FR2113883A1 - - Google Patents

Info

Publication number
FR2113883A1
FR2113883A1 FR7140157A FR7140157A FR2113883A1 FR 2113883 A1 FR2113883 A1 FR 2113883A1 FR 7140157 A FR7140157 A FR 7140157A FR 7140157 A FR7140157 A FR 7140157A FR 2113883 A1 FR2113883 A1 FR 2113883A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7140157A
Other languages
French (fr)
Other versions
FR2113883B1 (da
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of FR2113883A1 publication Critical patent/FR2113883A1/fr
Application granted granted Critical
Publication of FR2113883B1 publication Critical patent/FR2113883B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FR7140157A 1970-11-10 1971-11-09 Expired FR2113883B1 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9891970A JPS4920766B1 (da) 1970-11-10 1970-11-10

Publications (2)

Publication Number Publication Date
FR2113883A1 true FR2113883A1 (da) 1972-06-30
FR2113883B1 FR2113883B1 (da) 1975-08-01

Family

ID=14232524

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7140157A Expired FR2113883B1 (da) 1970-11-10 1971-11-09

Country Status (15)

Country Link
JP (1) JPS4920766B1 (da)
AR (1) AR193625A1 (da)
BE (1) BE775106A (da)
CA (1) CA951314A (da)
CH (1) CH559716A5 (da)
DD (1) DD95372A5 (da)
DE (1) DE2155546A1 (da)
DK (1) DK128733B (da)
ES (1) ES396708A1 (da)
FR (1) FR2113883B1 (da)
GB (1) GB1362956A (da)
HU (1) HU162848B (da)
NL (1) NL7115393A (da)
NO (1) NO133325C (da)
SU (1) SU433670A3 (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2196812A1 (da) * 1972-08-24 1974-03-22 Ono Pharmaceutical Co
FR2290895A1 (fr) * 1974-11-14 1976-06-11 Upjohn Co Esters d'analogues de prostaglandines, leur preparation et leur utilisation

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163108A (en) * 1967-02-16 1979-07-31 Lever Brothers Company Prostaglandins
US3984424A (en) * 1972-11-08 1976-10-05 Pfizer Inc. P-biphenyl esters of 15-substituted-ω-pentanorprostaglandins
US3989736A (en) * 1973-01-08 1976-11-02 Pfizer Inc. Prostaglandin 5-indanyl esters
US3968140A (en) * 1974-01-08 1976-07-06 The Upjohn Company Substituted anilide esters of PGE1
US3931281A (en) * 1974-01-08 1976-01-06 The Upjohn Company Substituted anilide ester of PGA2
US3890372A (en) * 1974-01-08 1975-06-17 Upjohn Co Amino substituted phenyl and naphthyl esters of PGF{HD 2{301 {B - type compounds
US3959319A (en) * 1974-01-08 1976-05-25 The Upjohn Company Phenyl and naphthyl esters of PGF2 α type prostaglandins
US3962289A (en) * 1974-01-08 1976-06-08 The Upjohn Company Esters of PGA2 and p-tritylphenol
US3988355A (en) * 1974-01-08 1976-10-26 The Upjohn Company Substituted phenyl and naphthyl esters of PGE1
US4013707A (en) * 1974-01-08 1977-03-22 The Upjohn Company Substituted phenyl esters of PGA1
US3932486A (en) * 1974-01-08 1976-01-13 The Upjohn Company Substituted tolyl esters of PGA2
US3969464A (en) * 1974-01-08 1976-07-13 The Upjohn Company Polycyclic aromatic esters of PGA1
US3931285A (en) * 1974-01-08 1976-01-06 The Upjohn Company Substituted tolyl esters of PGE1
US4013693A (en) * 1974-01-08 1977-03-22 The Upjohn Company Substituted phenyl esters of PGA1
US3948970A (en) * 1974-01-08 1976-04-06 The Upjohn Company Substituted tolyl esters of PGA1
US3987067A (en) * 1974-01-08 1976-10-19 The Upjohn Company Substituted aromatic esters of PGF2.sub.α
US4042606A (en) * 1974-12-12 1977-08-16 The Upjohn Company Substituted phenyl esters of PGA2
US4058551A (en) * 1974-12-12 1977-11-15 The Upjohn Company Substituted phenyl esters of PGA2
JPS5420344U (da) * 1977-07-13 1979-02-09
ES2213504T1 (es) † 1988-09-06 2004-09-01 Pfizer Health Ab Derivados de prostaglandina para el tratamiento del glaucoma o hipertension ocular.
AU8475301A (en) 2000-08-07 2002-02-18 Univ Vanderbilt Detection of cox-2 activity and anandamide metabolites
US7314709B2 (en) 2002-08-06 2008-01-01 Vanderbilt University Compositions and methods for detecting and quantifying COX-2 activity by lipoamino acid metabolism
EP2084124B9 (en) 2006-10-02 2015-07-01 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
JP5925158B2 (ja) * 2013-06-04 2016-05-25 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
JP6030168B2 (ja) * 2015-03-09 2016-11-24 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
JP6306067B2 (ja) * 2016-01-08 2018-04-04 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
CN109400513B (zh) * 2018-11-26 2020-06-09 武汉嘉诺康医药技术有限公司 一种卡前列素的纯化方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2196812A1 (da) * 1972-08-24 1974-03-22 Ono Pharmaceutical Co
FR2290895A1 (fr) * 1974-11-14 1976-06-11 Upjohn Co Esters d'analogues de prostaglandines, leur preparation et leur utilisation

Also Published As

Publication number Publication date
BE775106A (fr) 1972-03-01
DE2155546A1 (da) 1972-05-18
DK128733B (da) 1974-06-24
DD95372A5 (da) 1973-02-05
ES396708A1 (es) 1975-04-16
SU433670A3 (da) 1974-06-25
HU162848B (da) 1973-04-28
GB1362956A (en) 1974-08-07
NL7115393A (da) 1972-05-15
CA951314A (en) 1974-07-16
AR193625A1 (es) 1973-05-11
CH559716A5 (da) 1975-03-14
JPS4920766B1 (da) 1974-05-27
NO133325B (da) 1976-01-05
FR2113883B1 (da) 1975-08-01
NO133325C (da) 1976-04-12

Similar Documents

Publication Publication Date Title
NO133325C (da)
AR204384A1 (da)
ATA96471A (da)
AU2044470A (da)
AU1146470A (da)
AU1473870A (da)
AU2085370A (da)
AU2017870A (da)
AU1833270A (da)
AU1716970A (da)
AU1517670A (da)
AU1326870A (da)
AU1336970A (da)
AR195465A1 (da)
AU1689770A (da)
AU1879170A (da)
AU1328670A (da)
AU1343870A (da)
AU1277070A (da)
AU1247570A (da)
AU1235770A (da)
AU1581370A (da)
AU1591370A (da)
AU1603270A (da)
AU1189670A (da)

Legal Events

Date Code Title Description
ST Notification of lapse